SCHEMBL25614555

SCHEMBL25614555

Cc1cc(F)c(P)cc1/C=N/Nc1nc(-c2ccccc2C)cs1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 6/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ GUSB P08236 2/20 0.45
▸ MAOA P21397 2/20 0.42
▸ MAOB P27338 1/20 0.42
▸ EGFR P00533 2/20 0.41
▸ MGAM O43451 1/20 0.41
▸ SI P14410 1/20 0.41
▸ MGAM2 Q2M2H8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25614001 0.97 DHODH (0.48) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25614201 0.89 DHODH (0.48) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25614112 0.84 EGFR (0.50) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25613810 0.83 DHODH (0.64) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25613755 0.82 DHODH (0.56) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25613698 0.81 MEN1 (0.62) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25613688 0.80 EGFR (0.52) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25614544 0.78 DHODH (0.53) DHODHMAPTSMN1; SMN2GAA
SCHEMBL25614252 0.75 DHODH (0.65) DHODHMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL25613990 0.73 DHODH (0.69) DHODHMEN1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190713-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190713-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF SARS1, EIF2AK2, NSUN3 DHODH 2268/4885MEN1 4853/4885MAPT 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback